A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A
Open Access
- 11 October 2024
- Vol. 9 (10) , 103939
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Predictors of immune checkpoint inhibitor-related adverse events in older patients with lung cancer: a prospective real-world analysisJournal of Cancer Research and Clinical Oncology, 2023
- Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer—a study in AIO oncologistsESMO Open, 2023
- Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R StudyJournal of Thoracic Oncology, 2022
- Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Real-World Incidence of Pneumonitis in Patients Receiving DurvalumabClinical Lung Cancer, 2022
- Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON)Lung Cancer, 2021
- Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)Clinical Lung Cancer, 2021
- A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients – the ELDERS studyESMO Open, 2021
- Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)The Lancet Oncology, 2012
- Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 1997